Glimigrand-Mv 2.2MG Tab

Tablet

Type 2 diabetes mellitus (when diet and exercise alone are not enough); helps control blood glucose in adults.

Glimepiride (a sulfonylurea) increases insulin release from the pancreas. Metformin (a biguanide) reduces glucose production in the liver and improves insulin sensitivity, helping the body use glucose better.

Tablet for oral use. Take exactly as prescribed, usually once or twice daily with meals to reduce stomach upset and risk of low sugar. Swallow whole with water; do not skip meals while taking this medicine.

Hypoglycaemia (low blood sugar), nausea, vomiting, diarrhoea, abdominal pain, loss of appetite, headache, dizziness, weight gain, metallic taste

Risk of hypoglycaemia (especially if meals are skipped, excessive exercise, or alcohol use); metformin may rarely cause lactic acidosis (higher risk in kidney/liver impairment, dehydration, severe infection, heart failure, or alcohol abuse). Not recommended in severe renal impairment; kidney function should be monitored. Use caution in elderly. Temporarily stop metformin before/after iodinated contrast procedures or major surgery as advised by doctor. Seek urgent care for symptoms of lactic acidosis (rapid breathing, severe weakness, abdominal pain, unusual sleepiness).

Alcohol (increases risk of hypoglycaemia/lactic acidosis), insulin or other antidiabetics (additive hypoglycaemia), beta-blockers (may mask hypoglycaemia), corticosteroids/thiazide diuretics (may raise glucose), ACE inhibitors (may increase hypoglycaemia risk), fluoroquinolones (glucose disturbances), cimetidine (may increase metformin levels), iodinated contrast media (kidney injury/lactic acidosis risk), NSAIDs/salicylates (may increase hypoglycaemia)

Store below 25°C in a cool, dry place. Protect from moisture and direct light. Keep out of reach of children.

Amaryl M 2 Tablet, Glimy M 2 Tablet, Glycomet-GP 2 Tablet, Glime-M 2 Tablet, Glimiprex-M 2 Tablet